Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK.
Trends Mol Med. 2011 Dec;17(12):699-706. doi: 10.1016/j.molmed.2011.09.002. Epub 2011 Oct 19.
Psychiatric genetics research, as exemplified by the DISC1 gene, aspires to inform on mental health etiology and to suggest improved strategies for intervention. DISC1 was discovered in 2000 through the molecular cloning of a chromosomal translocation that segregated with a spectrum of major mental illnesses in a single large Scottish family. Through in vitro experiments and mouse models, DISC1 has been firmly established as a genetic risk factor for a spectrum of psychiatric illness. As a consequence of its protein scaffold function, the DISC1 protein impacts on many aspects of brain function, including neurosignaling and neurodevelopment. DISC1 is a pathfinder for understanding psychopathology, brain development, signaling and circuitry. Although much remains to be learnt and understood, potential targets for drug development are starting to emerge, and in this review, we will discuss the 10 years of research that has helped us understand key roles of DISC1 in psychiatric disease.
精神遗传学研究以 DISC1 基因为例,旨在阐明精神健康病因,并为干预措施提供改进策略。DISC1 于 2000 年通过对一个染色体易位的分子克隆发现,该易位与一个苏格兰大家庭中的一系列主要精神疾病有关。通过体外实验和小鼠模型,DISC1 已被确定为一系列精神疾病的遗传风险因素。由于其蛋白支架功能,DISC1 蛋白影响大脑功能的许多方面,包括神经信号和神经发育。DISC1 是理解精神病理学、大脑发育、信号和电路的先驱。尽管还有很多需要学习和理解,但药物开发的潜在目标开始出现,在这篇综述中,我们将讨论这 10 年来的研究,这些研究帮助我们了解了 DISC1 在精神疾病中的关键作用。